BNP Paribas Financial Markets’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-465,302
| Closed | -$1.95M | – | 3365 |
|
|
2023
Q1 | $1.95M | Buy |
465,302
+191,539
| +70% | +$804K | ﹤0.01% | 1349 |
|
|
2022
Q4 | $1.65M | Sell |
273,763
-56,043
| -17% | -$337K | ﹤0.01% | 1340 |
|
|
2022
Q3 | $1.92M | Buy |
329,806
+309,640
| +1,535% | +$1.8M | ﹤0.01% | 1453 |
|
|
2022
Q2 | $120K | Buy |
+20,166
| New | +$120K | ﹤0.01% | 2662 |
|
|
2020
Q2 | – | Sell |
-272
| Closed | -$250 | – | 3801 |
|
|
2020
Q1 | $250 | Hold |
272
| – | – | ﹤0.01% | 3552 |
|
|
2019
Q4 | $430 | Sell |
272
-5,827
| -96% | -$9.21K | ﹤0.01% | 3589 |
|
|
2019
Q3 | $5.11K | Hold |
6,099
| – | – | ﹤0.01% | 3626 |
|
|
2019
Q2 | $5.24K | Sell |
6,099
-7,757
| -56% | -$6.67K | ﹤0.01% | 3612 |
|
|
2019
Q1 | $13.4K | Buy |
13,856
+12,954
| +1,436% | +$12.6K | ﹤0.01% | 3393 |
|
|
2018
Q4 | $662 | Sell |
902
-768
| -46% | -$564 | ﹤0.01% | 3296 |
|
|
2018
Q3 | $3.61K | Hold |
1,670
| – | – | ﹤0.01% | 3489 |
|
|
2018
Q2 | $8.32K | Buy |
+1,670
| New | +$8.32K | ﹤0.01% | 3219 |
|
|
2016
Q1 | – | Sell |
-3,819
| Closed | -$47K | – | 3558 |
|
|
2015
Q4 | $47K | Buy |
3,819
+416
| +12% | +$5.12K | ﹤0.01% | 2848 |
|
|
2015
Q3 | $49.7K | Buy |
3,403
+2,034
| +149% | +$29.7K | ﹤0.01% | 2869 |
|
|
2015
Q2 | $26.7K | Buy |
1,369
+1,019
| +291% | +$19.9K | ﹤0.01% | 2863 |
|
|
2015
Q1 | $6.34K | Buy |
+350
| New | +$6.34K | ﹤0.01% | 3016 |
|
|
2014
Q4 | – | Sell |
-822
| Closed | -$19.9K | – | 3586 |
|
|
2014
Q3 | $19.9K | Buy |
+822
| New | +$19.9K | ﹤0.01% | 2703 |
|
|
2014
Q2 | – | Sell |
-13
| Closed | -$389 | – | 3570 |
|
|
2014
Q1 | $389 | Sell |
13
-133
| -91% | -$3.98K | ﹤0.01% | 2646 |
|
|
2013
Q4 | $2.81K | Sell |
146
-3,003
| -95% | -$57.7K | ﹤0.01% | 2959 |
|
|
2013
Q3 | $51K | Sell |
3,149
-1,354
| -30% | -$21.9K | ﹤0.01% | 2183 |
|
|
2013
Q2 | $47.3K | Buy |
+4,503
| New | +$47.3K | ﹤0.01% | 2350 |
|